Invictus MD Strategies Awaiting Canadian Cannabis Legalization

Invictus MD Strategies Corp. (OTCBB: IVITF), is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the Access to Cannabis for Medical Purposes Regulations (ACMPR) located in both Alberta and Ontario, including Acreage Pharms Ltd. and AB Laboratories Inc.; and Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd. The company has the largest land package in Canada for building cultivation facilities as demand increases.

On April 20th 2017, Invictus announced that it has engaged Canaccord Genuity Corp. and Eventus Capital Corp., as co-lead underwriters and joint-bookrunners, pursuant to which Underwriters have agreed to purchase, on a bought deal private placement basis, $40 million aggregate principal amount of convertible debentures at a price of $1,000 per Convertible Debenture. Invictus also granted the Underwriters an option to purchase up to an additional $10 million aggregate principal amount of convertible debentures on the same terms as the Convertible Debentures.


On the flip side, it also announced that it has provided Acreage Pharms Ltd, a licensed producer of Cannabis under the Access to Cannabis for Medicinal Purposes Regulations (“ACMPR”), with notification that it intends to exercise its option to acquire 100% of Acreage Pharms’ shares from its current shareholders. The move is drive by company’s continued effort to focus on expansions, which are brownfield and modular in nature.


Prior to this, Invictus also announced that AB Laboratories Inc., a Licensed Producer under ACMPR, will provide their unique products in Canopy Growth Corporation’s (TSX: WEED), curated CraftGrow line on Tweed Main Street’s online store, that brings high quality cannabis grown by a diverse set of producers. Tweed Main Street is an opportunity in the legal market where patients can see what is available through the convenience of an online store.

After the successful development and acquisition of these facilities (i.e. both AB Laboratories Inc. & Acreage Pharms Ltd), Invictus MD anticipates that it will have the capacity to supply more than 50,000 kg of cannabis by 2020. This creates an attractive value proposition in the burgeoning cannabis market.


Canada is on the global stage for cannabis legalization and moves closer to making history by being the first G-7 nation to legalize and regulate access to cannabis.  Therefore, the business risk profile of companies like Invictus are expected to derive significant strength due to the expected demand that will come with cannabis legalization for the recreational market.


IVITF operates in a Marijuana industry that has rapidly & recently turned into a multi-billion-dollar massive growth market across US and Canada with many new states legalizing it. According to a recent estimate, the cannabis market crossed $6.7 billion from the U.S. alone in 2016. On a conservative basis, combined recreational cannabis sales could total an estimated $45-$50 billion by 2020, if cannabis is legalized across the United States of America & Canada.


The company’s stock has unsurprisingly found some strength in the recent past. It has been powering due to the favorable impact of the company’s recent announcements and growing popularity & demand of the industry.


Description & about the Company: Invictus MD Strategies Corp is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR including an investment in a fully licensed facility, AB Laboratories Inc. as well as the option to now acquire 100% of Acreage Pharms Ltd.; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd. Invictus MD targets small and mid-size companies with proven brands, strong customer focus, and significant growth potential. Invictus directs the strategy towards profitability and growth for each of their portfolio companies. They assist the companies with business process integration and by structuring and deploying proper capital to support sustained growth.


It is broadly focused on the following two verticals:

  1. Cannabis cultivation in Canada
  2. Cannabis fertilizer and nutrients

 About AB labs & AB Ventures: AB Labs, which maintains a 16,000-square foot facility located near Hamilton, Ontario, has successfully conducted test crops and is currently operating at half capacity, with full production capacity scheduled by the end of May 2017. AB Ventures Inc.’s (“AB Ventures”), a company formed to develop a second licensed expansion facility through it’s common ownership with AB Labs, is expected to close a 100-acre acquisition on May 1, 2017, and if licensed under the ACMPR, construction of production facilities totaling 250,000 square feet will begin and be used for future cannabis cultivation. With licensing in place as expected, production at AB Ventures is anticipated to start as early as December 2017. Considering the magnitude of AB Ventures’ land acquisition and future production facilities, and assuming AB Ventures obtains a license to produce the quantity forecasted, Invictus MD anticipates the combined production capacity of both AB Labs and AB Ventures to exceed 25,000 kilograms in 2020. 

About Acreage Pharms: Acreage Pharms hold a 6,800-sq. ft. facility already constructed with a 30,000-sq. ft. expansion plan with an option to add an additional 20,000 sq ft second floor located on 150-acre property to accommodate three-phase expansion plan. Cultivation license has already been received on March 29, 2017

Valuation of Acquisitions:

To date the company acquired and sold the following assets:

Industry Outlook: According to Deloitte, Canadian recreational cannabis could reach retail sales of $6.0 billion by 2021. The following graph reflects the estimated Supply, demand and pricing.

Timeline of Recent progress & outlook over the near term:

  • March 2017 Closed $16.21 million bought deal through Canaccord & Eventus Capital
  • March 2017 AB Labs commences cultivation
  • March 2017 Listed on TSX-V
  • March 2017 Acreage Pharms received license under ACMPR
  • December 2017 Estimated cultivation license for AB Ventures. Production profile for AB Labs & AB Ventures forecasted to reach 25,000 kgs by 2020
  • December 2020 Acreage Pharms production profile forecasted to reach 25,000 kgs by 2020

Key Stock Influences & Risk Factors:

Some key influences that might govern future stock price performance include:

  • Invictus’s distribution operational & marketing initiatives are still at nascent stage. Though, the company is making rapid progress, and the commercialization is underway. The company’s (including its subsidiaries/associates) ability to revamp its off-take strategies and to align with mainstream markets would hold the key over the near to medium term.
  • The Company’s fortunes are significantly dependent on timely approvals and positive regulations in the subject Industry. Therefore, any positive or negative outcome/announcement would act as an immediate & strong trigger for its stock.
  • Invictus’s ability to maintain its liquidity and financial flexibility to fund its incremental capital requirements. Since cannabis is still not fully legalized, it is not easy for the company to access capital on agreeable terms. Also, any additional equity raise is exposed to significant dilution risk.
  • Company’s ability to timely deliver under its signed contract.

Earnings Review: The Company is in the process of reporting its latest financials. It has published no financial statements in the recent past.


Liquidity and Capital Resources: The Company’s ability to maintain its liquidity & financial flexibility is dependent upon its ability to develop additional sources of capital and ultimately to successfully achieve profitable operations.


Capitalization Structure as per the investor presentation deck, dated April 5th 2017.

Note: The figures are extracted from Company’s latest investor presentation & therefore may not include the most recent developments, as outlined in the report.


Stock Performance:

On Friday, April 21st, 2017, Invictus shares declined by -2.67% to $1.50 on an average volume of 248,454 shares exchanging hands. Market capitalization is $57.75 million. The current RSI is 62.97

In the past 52 weeks, shares of Invictus have traded as low as $0.18 and as high as $1.63.

At $1.450, shares of Invictus are trading above their 50-day moving average (MA) at $1.25 and above their 200-day MA at $0.94.

The present support and resistance levels for the stock are at $1.4476 & $1.5526 respectively.



About Traders News Source:


Traders News Source recent profiles and track record, 534% in verifiable potential gains for our members on 3 small cap alerts alone!


January 31st, 2017 (NASDAQ: HIMX) opened at $5.10/share and hit a high of $9.68/share March 24th, 2017 for gains of 89% within 60 days-


February 6th, 2017- (NASDAQ: SCON) opened at $1.12/share hit a high of $1.80/share within 10 days our member potential gains- 60% –


March 6th, 2017 (OTC: USRM) opened at .035/share and hit over .17/share within 25 days for gains of 385% for our members-


These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So, if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.


We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.


***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP – SMS/text alert service for free, simply text the word “Traders” to the phone number “25827” from your cell phone***






Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.


Traders News Source has not been compensated for this report by anyone and the opinions if any are that of the author Vikas Agrawal, CFA. Author’s Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I, wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in the article.


This web site, published by TNS LLC, and is an investment newsletter that is built on the premise of assisting individual investors in learning about investing. Our goal as publishers of financial information is to provide research and analysis of investments to our subscribers. TNS LLC does not give buy or sell recommendations. We do purchase distribution rights from analyst, financial writers and bloggers for a fee that may be licensed to issue price targets and recommendations. Furthermore, we encourage you to speak to a licensed professional prior to making an investment in any type of publicly traded security.


We do sell advertising to other companies including brokerage firms, web sites, publicly traded issuers, investor relations firms, and investment publications, among others. TNS LLC makes no warranty as to the policies of these organizations, and in no way endorses their offers, services, or the content of their advertisements.


When an advertiser is a publicly traded company or a third party acting on behalf of a public company, we fully disclose all compensation in the email advertisement. Such disclosure is included in a disclosure statement in each of the advertisements sent via email.


17B Disclosure


Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.


PLEASE NOTE WELL: TNS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.


Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D.


TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.


The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur.


Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.